ANVS RSI Chart
Last 7 days
38.3%
Last 30 days
-8.8%
Last 90 days
-21.4%
Trailing 12 Months
-39.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2021 | 877.3K | 597.1K | 316.9K | 36.8K |
2020 | 840.7K | 946.3K | 1.1M | 1.2M |
2019 | 0 | 0 | 0 | 735.1K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 20, 2023 | mccarthy reid | acquired | - | - | - | - |
Nov 20, 2023 | hoffman michael b | acquired | 1,000,000 | 6.07 | 164,745 | - |
Nov 20, 2023 | maccecchini maria-luisa | acquired | 249,999 | 6.07 | 41,186 | president and ceo |
Nov 20, 2023 | bruck claudine | acquired | 6,070 | 6.07 | 1,000 | - |
Nov 20, 2023 | white mark k. | acquired | 12,140 | 6.07 | 2,000 | - |
Nov 20, 2023 | hagopian henry iii | acquired | 5,001 | 6.07 | 824 | chief financial officer |
Nov 20, 2023 | mccarthy reid | acquired | 5,001 | 6.07 | 824 | - |
Nov 20, 2023 | hoffman michael b | acquired | 999,668 | 6.1 | 163,880 | - |
Nov 20, 2023 | bruck claudine | acquired | - | - | - | - |
Nov 20, 2023 | maccecchini maria-luisa | acquired | 249,917 | 6.1 | 40,970 | president and ceo |
Which funds bought or sold ANVS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -223,821 | - | -% |
May 15, 2024 | MARSHALL WACE, LLP | sold off | -100 | -609,284 | - | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | added | 42.37 | -41,480 | 399,840 | 0.01% |
May 15, 2024 | Royal Bank of Canada | reduced | -90.00 | -1,000 | - | -% |
May 15, 2024 | CITADEL ADVISORS LLC | new | - | 12.00 | 12.00 | -% |
May 15, 2024 | STATE STREET CORP | added | 23.79 | -93,398 | 346,707 | -% |
May 15, 2024 | MORGAN STANLEY | added | 399 | 58,341 | 85,157 | -% |
May 15, 2024 | ADAGE CAPITAL PARTNERS GP, L.L.C. | reduced | -12.39 | -2,360,990 | 2,975,000 | 0.01% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -229,673 | - | -% |
May 15, 2024 | Cetera Advisors LLC | new | - | 121,678 | 121,678 | -% |
Unveiling Annovis Bio Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Annovis Bio Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Annovis Bio Inc News
Income Statement (Quarterly) | ||||||||||
Description | (%) Q/Q | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | - | - | - | 7,414 | 106,131 | 204,847 | 586,903 | 208,261 | 157,438 | - |
Operating Expenses | 107.4% | 5,920,091 | 2,853,770 | 2,534,150 | 3,229,210 | 1,909,673 | 1,603,757 | 2,543,629 | 583,162 | 870,962 |
S&GA Expenses | 106.1% | 3,035,946 | 1,472,969 | 709,648 | 839,627 | 497,470 | 884,859 | 1,687,151 | 516,716 | 108,780 |
R&D Expenses | 108.9% | 2,884,145 | 1,380,801 | 1,824,502 | 2,389,583 | 1,412,203 | 718,898 | 856,478 | 66,446 | 762,182 |
EBITDA Margin | -1115.5% | -394 | -32.43 | -14.13 | -9.37 | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -107.7% | -5,914,641 | -2,848,216 | -2,524,602 | -3,199,673 | -1,704,613 | -1,006,354 | -2,309,490 | -441,590 | -201,256 |
EBT Margin | -1115.5% | -394 | -32.43 | -14.13 | -9.37 | - | - | - | - | - |
Net Income | -107.7% | -5,914,641 | -2,848,216 | -2,524,602 | -3,199,673 | -1,704,613 | -1,006,354 | -2,309,490 | -441,590 | -201,256 |
Net Income Margin | -1115.5% | -394 | -32.43 | -14.13 | -9.37 | - | - | - | - | - |
Free Cashflow | -1.5% | -1,769,320 | -1,743,408 | -3,144,563 | -2,474,868 | - | - | - | - | - |
Balance Sheet | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Assets | -23.5% | 8.00 | 10.00 | 10.00 | 23.00 | 26.00 | 36.00 | 37.00 | 40.00 | 44.00 | 46.00 | 48.00 | 49.00 | 6.00 | 8.00 | 9.00 | 10.00 | 11.00 | 1.00 |
Current Assets | -23.5% | 8.00 | 10.00 | 10.00 | 23.00 | 26.00 | 36.00 | 37.00 | 40.00 | 44.00 | 46.00 | 48.00 | 49.00 | 6.00 | 8.00 | 9.00 | 10.00 | 11.00 | 1.00 |
Cash Equivalents | -45.5% | 3.00 | 6.00 | 6.00 | 16.00 | 17.00 | 28.00 | 32.00 | 36.00 | 43.00 | 46.00 | 47.00 | 49.00 | 6.00 | 8.00 | 9.00 | 10.00 | 11.00 | 0.00 |
Liabilities | -37.8% | 11.00 | 18.00 | 4.00 | 2.00 | 5.00 | 8.00 | 3.00 | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 2.00 | 1.00 | 0.00 | 1.00 | 1.00 | 3.00 |
Current Liabilities | 13.8% | 5.00 | 4.00 | 4.00 | 2.00 | 5.00 | 8.00 | 3.00 | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 2.00 | 1.00 | 0.00 | 1.00 | 1.00 | 2.00 |
Shareholder's Equity | 56.7% | -3.35 | -7.75 | 7.00 | 21.00 | 20.00 | 28.00 | 35.00 | 39.00 | 43.00 | 44.00 | 47.00 | 49.00 | 4.00 | 8.00 | 9.00 | 9.00 | 11.00 | - |
Retained Earnings | -0.9% | -111 | -110 | -88.05 | -73.33 | -63.79 | -54.05 | -46.33 | -39.90 | -33.96 | -28.73 | -22.81 | -19.96 | -17.44 | -14.24 | -12.53 | -11.53 | -9.22 | -8.78 |
Additional Paid-In Capital | 5.3% | 108 | 103 | 95.00 | 94.00 | 84.00 | 82.00 | 81.00 | 79.00 | 77.00 | 73.00 | 69.00 | 69.00 | 22.00 | 22.00 | 22.00 | 21.00 | 20.00 | 0.00 |
Shares Outstanding | 4.7% | 11.00 | 11.00 | 9.00 | 9.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 7.00 | 7.00 | - | - | - | - | - |
Float | - | - | - | - | 92.00 | - | - | - | 63.00 | - | - | - | 482 | - | - | - | 19.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 24.9% | -7,032 | -9,364 | -9,369 | -9,606 | -11,626 | -3,609 | -3,987 | -6,694 | -3,021 | -1,769 | -1,743 | -3,144 | -2,474 | -765 | -922 | -1,311 | -970 | -52.53 | -44.68 | -150 | -228 |
Share Based Compensation | -58.7% | 365 | 882 | 632 | 1,571 | 1,542 | 1,458 | 2,356 | 1,904 | 3,435 | 3,880 | 786 | 8.00 | 24.00 | 125 | 629 | 1,111 | - | -376* | - | - | 9.00 |
Cashflow From Financing | -49.6% | 4,415 | 8,765 | - | 8,572 | 7.00 | - | - | - | 5.00 | - | -25.46 | 46,766 | 3.00 | - | - | -45.39 | 12,089 | -1.86 | -3.62 | -81.43 | 530 |
Statements of Operations - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 6,514,920 | $ 7,786,056 |
General and administrative | 1,294,887 | 2,183,660 |
Total operating expenses | 7,809,807 | 9,969,716 |
Operating loss | (7,809,807) | (9,969,716) |
Other income: | ||
Interest income | 44,168 | 232,535 |
Change in fair value of warrants | 6,698,692 | |
Total other income | 6,742,860 | 232,535 |
Net loss before income taxes | (1,066,947) | (9,737,181) |
Income tax expense (benefit) | 0 | 0 |
Net loss | $ (1,066,947) | $ (9,737,181) |
Net loss per share (Note 9) | ||
Basic (dollars per share) | $ (0.10) | $ (1.19) |
Diluted (dollars per share) | $ (0.72) | $ (1.19) |
Weighted-average number of common shares used in computing net loss per share | ||
Basic | 10,625,065 | 8,194,990 |
Diluted | 10,824,771 | 8,194,990 |
Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 3,136,968 | $ 5,754,720 |
Prepaid expenses and other current assets | 4,676,327 | 4,453,544 |
Total current assets | 7,813,295 | 10,208,264 |
Total assets | 7,813,295 | 10,208,264 |
Current liabilities: | ||
Accounts payable | 4,106,832 | 1,292,837 |
Accrued expenses | 763,183 | 2,986,273 |
Total current liabilities | 4,870,015 | 4,279,110 |
Warrant liability | 6,297,308 | 13,680,000 |
Total liabilities | 11,167,323 | 17,959,110 |
Commitments and contingencies (Note 6) | ||
Stockholders' (deficit) | ||
Preferred stock - $0.0001 par value, 2,000,000 shares authorized and 0 shares issued and outstanding | ||
Common stock - $0.0001 par value, 70,000,000 and 70,000,000 shares authorized and 11,011,299 and 10,519,933 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 1,101 | 1,052 |
Additional paid-in capital | 107,970,905 | 102,507,189 |
Accumulated deficit | (111,326,034) | (110,259,087) |
Total stockholders' (deficit) | (3,354,028) | (7,750,846) |
Total liabilities and stockholders' deficit | $ 7,813,295 | $ 10,208,264 |